Joel Diamond, MD, Co-Founder & Chief Medical Officer of Aranscia
Pharmacogenomics, also referred to as PGx, is the use of a patient’s genetic makeup to guide safer, more effective medication choices and dosing in everyday…
Continue Reading
Spesana logo
What You Should Know:
– Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology…
Continue Reading
Kristine Ashcraft, President and Founder of YouScript (an Aranscia company)
What if we advised people to wear seatbelts only on certain days or when driving on specific highways? Clearly, this would result in real and…
Continue Reading
What You Should Know:
– Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
– The multi-phase partnership focuses on developing…
Continue Reading
The world of healthcare is constantly growing and evolving. We are constantly coming up with new ideas and developing new technologies all in the spirit of making things better, not only for our own…
Continue Reading
Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation, a leading medical genetics company, today announced that Aranscia has acquired select assets of the YouScript personalized medication management platform…
Continue Reading
